Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
When activated, AMPK promotes catabolic processes that generate ATP (like fatty acid oxidation and glucose uptake) and inhibits anabolic processes that consume ATP (like protein synthesis and lipid synthesis)
Tirzepatide begins at 2.5mg weekly and can increase to 15mg weekly
In the SURMOUNT-1 clinical trial, tirzepatide produced up to 23% body weight loss, outperforming every prior pharmacological treatment
Beyond weight loss, GLP-1s are currently approved for additional uses for people who have obesity, including Wegovy for cardiovascular risk reduction, Zepbound for sleep apnea, and Ozempic for slowing chronic kidney disease in people with Type 2 diabetes
Green preparation of holocellulose nanocrystals from burdock and their inhibitory effects against -amylase and -glucosidase
